IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management, LLC

Q3 2015 Holdings

Filed 2015-11-13 | 30 holdings | $32.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Coherus Biosciences Inc(CHRS)COM19249H103$17.4M870,26954.2%
Ascendis Pharma A/S(ASND)COM04351P101$14.4M811,15244.6%
Anacor Pharmaceuticals IncCOM032420101$138.7K1,178,4740.4%
DBV TechnologiesCOMF2927N109$45.6K693,8100.1%
GW PharmaceuticalsCOM36197T103$28.5K311,8530.1%
Heron Therapeutics Inc(HRTX)COM427746102$26.7K1,095,7340.1%
Regenxbio Inc(RGNX)COM75901B107$20.2K1,083,4540.1%
Zafgen IncCOM98885E103$17.3K541,4800.1%
Lipocine IncCOM53630X104$15.0K1,269,9210.0%
Akari Therapeutics PlcCOM00972G108$12.7K527,8420.0%
Avalanche Biotechnologies IncCOM05337G107$11.4K1,382,7350.0%
Alcobra LtdCOMM2239P109$9.1K1,500,0000.0%
Flamel Technologies S.A.COM338488109$8.2K500,0000.0%
Arca biopharma IncCOM00211Y100$7.6K1,541,3310.0%
Cynapsus Therapeutics IncCOM23257Y701$5.9K367,4270.0%
ProNAI Therapeutics IncCOM74346L101$5.1K250,0000.0%
Stemline Therapeutics IncCOM85858C107$4.0K451,4000.0%
Ocera TherapeuticsCOM67552A108$2.2K703,7300.0%